Influenza and obesity: Will vaccines and antivirals protect?

Journal of Infectious Diseases

Volumn 205, Issue 2, 2012, Pages 172-173

  Beck, Melinda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ANTIGEN PRESENTATION; CD8+ T LYMPHOCYTE; CELL REGENERATION; COMORBIDITY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; MORTALITY; NATURAL KILLER CELL; NONHUMAN; NOTE; OBESITY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SEASONAL INFLUENZA; VIRAL CLEARANCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; MALE; OBESITY; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR;

EID: 84555186961     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir740     Document Type: Note

References (15)

1. World Health Organization. Obesity and overweight. 2011; http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 20 August 2011.
2. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009; 121:21-33.
3. Hanslik T, Boelle PY, Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A (H1N1) 2009 influenza virus, France, 2009-2010. PLoS Curr 2010; 2RRN1150.
4. Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52:301-12.
5. Kerkhove Van, Vandemaele KA, Shinde V, et al. Risk factors for severe outcome following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011; 8:e1001053.
6. Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS One 2010; 5:e9694.
7. Díaz E, Rodríguez A, Martin-Loeches I, et al. Impact of obesity in patients infected with 2009 influenza A (H1N1). Chest 2011; 139:382-6.
8. Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011; 53: 413-21.
9. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254:3187-9. (Pubitemid 16206968)
10. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 1986; 314:1393. (Pubitemid 16122481)
11. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006; 39:137-41. (Pubitemid 43675257)
12. Smith AG, Sheridan PA, Harp JB, Beck MA. Increased mortality and altered immune response in obese mice infected with influenza virus. J Nutr 2007; 137:1236-43. (Pubitemid 46701917)
13. Smith AG, Sheridan PA, Tseng R, Sheridan J, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD81 T cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009; 126:268-79.
14. Karlsson EA, Sheridan PA, Beck MA. Dietinduced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010; 184:3127-33.
15. Karlsson EA, Sheridan PA, Beck MA. Dietinduced obesity in mice reduces the maintenance of influenza-specific CD81 memory T cells. J Nutr 2010; 140:1691-7.